Details for 2010016112

Up to date per 01.04.2026

Actions

Title / Product Name

EXENDIN ZUR DIABETESBEHANDLUNG UND GEWICHTSREDUCIERUNG

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2010016112

EP Publication Number

2347762

E-Number

1129139

Language

PCT Number

Publication Date

27.07.2011 A

08.05.2019 B1

Registration Date

08.05.2019

AT Publication Date

15.05.2019

Application Date

18.08.2006

Registration Number

Priorities

19.08.2005

709604 P

03.03.2006

779216 P

IPC

A61K 38/26 20060101AFI20110616BHEP

Maximum Duration of Protection

18.08.2026

Owner

Amylin Pharmaceuticals, LLC9360 Towne Centre Drive San Diego, CA 92121US

AstraZeneca Pharmaceuticals LP1800 Concord Pike Wilmington, DEUS

Representative

Barger Werner Dipl.Ing., Israiloff Peter Dipl.Ing. Dr.techn.Operngasse 41010 WienAT

Inventor

Fineman, Markc/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre Drive San Diego, CA 92121US

Macconell, Leighc/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre Drive San Diego, CA 92121US

Taylor, Kristinc/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre Drive San Diego, CA 92121US